首页> 外文OA文献 >Predictors of Residual Viremia in HIV‐Infected Patients Successfully Treated with Efavirenz and Lamivudine plus either Tenofovir or Stavudine

【2h】

Predictors of Residual Viremia in HIV‐Infected Patients Successfully Treated with Efavirenz and Lamivudine plus either Tenofovir or Stavudine

机译：艾滋病毒感染患者残留病毒血症的预测因素成功地用Efaviraz和Lamivudine加上替诺福韦或史蒂芬治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Diane V. Havlir; Kersten K. Koelsch; Matthew C. Strain; Nicolas Margot; Biao Lu; Caroline C. Ignacio; Michael D. Miller; Joseph K. Wong;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Predictors of Residual Viremia in HIV-Infected Patients Successfully Treated with Efavirenz and Lamivudine plus either Tenofovir or Stavudine. [J] . Havlir DV, Koelsch KK, Strain MC, The Journal of Infectious Diseases . 2005,第7期

机译：用依非韦伦和拉米夫定加替诺福韦或司他夫定成功治疗的HIV感染患者中残留病毒血症的预测指标。
2. Biological effects of two antiretroviral tritherapy (stavudine-lamivudine-nevirapine and emitricitabine-tenofovir-efavirenz) in patients HIV positive in Abidjan (C?te d’Ivoire) [J] . Tovi Wahon Marie Odile, Kouakou Koffi, Ouattara Fatou Shchérazade Epouse Soro, International Journal of Biosciences . 2015,第5期

机译：两种抗逆转录病毒三联疗法（stavudine-lamivudine-nevirapine和Etricitabine-tenofovir-efavirenz）对阿比让（科特迪瓦）HIV阳性患者的生物学影响
3. COMPARISON OF THAI GOVERNMENT MANUFACTURED TENOFOVIR (TENOFOVIR GPO300) WITH PRIVATELY MANUFACTURED TENOFOVIR (VIREAD) USED ALONG WITH LAMIVUDINE AND EFAVIRENZ TO TREAT THAI HIV PATIENTS [J] . Manosuthi Weerawat, Thongyen Supeda, Nilkamhang Samruay, The Southeast Asian journal of tropical medicine and public health . 2015,第Pta1期

机译：泰国政府制造的替诺福韦（TENOFOVIR GPO300）与民用制造的替诺福韦（VIREAD）以及拉米夫定和依法夫仑治疗泰国艾滋病毒患者的比较
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals [O] . Graeme J. Moyle, Chloe Orkin, Martin Fisher, -1

机译：持续使用阿巴卡韦/拉米夫定加依非韦伦或用依非韦伦/恩曲他滨/替诺福韦DF替代治疗高胆固醇血症HIV-1感染者的随机比较试验
7. A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals. [O] . Graeme J Moyle, Chloe Orkin, Martin Fisher, 2015

机译：在高胆固醇血症HIV-1感染个体中持续使用阿巴卡韦/拉米夫定加依法韦仑或用依法韦仑/恩曲他滨/替诺福韦DF替代的随机对照试验。

Predictors of Residual Viremia in HIV‐Infected Patients Successfully Treated with Efavirenz and Lamivudine plus either Tenofovir or Stavudine

著录项

引文网络

相似文献

相关主题

期刊订阅